These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36879638)

  • 21. Knowledge, Misperceptions, Preparedness, and Barriers towards Lassa Fever Control among Health Care Workers in a Tertiary Institution in Enugu, Nigeria.
    Ndu AC; Kassy WC; Ochie CN; Arinze-Onyia SU; Okeke TA; Aguwa EN; Okwor TJ; Chinawa A
    J Health Care Poor Underserved; 2019; 30(3):1151-1164. PubMed ID: 31422994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measures to control protracted large Lassa fever outbreak in Nigeria, 1 January to 28 April 2019.
    Dan-Nwafor CC; Furuse Y; Ilori EA; Ipadeola O; Akabike KO; Ahumibe A; Ukponu W; Bakare L; Okwor TJ; Joseph G; Mba NG; Akano A; Olayinka AT; Okoli I; Okea RA; Makava F; Ugbogulu N; Oladele S; Namara G; Muwanguzi EN; Naidoo D; Mutbam SK; Okudo I; Woldetsadik SF; Lasuba CL; Ihekweazu C
    Euro Surveill; 2019 May; 24(20):. PubMed ID: 31115314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hand hygiene among oral health care providers in public institutions in Edo state even in the wake of Lassa fever.
    Harrison O; Joan E
    Afr Health Sci; 2023 Dec; 23(4):183-194. PubMed ID: 38974267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiologic and Clinical Features of Lassa Fever Outbreak in Nigeria, January 1-May 6, 2018.
    Ilori EA; Furuse Y; Ipadeola OB; Dan-Nwafor CC; Abubakar A; Womi-Eteng OE; Ogbaini-Emovon E; Okogbenin S; Unigwe U; Ogah E; Ayodeji O; Abejegah C; Liasu AA; Musa EO; Woldetsadik SF; Lasuba CLP; Alemu W; Ihekweazu C;
    Emerg Infect Dis; 2019 Jun; 25(6):1066-1074. PubMed ID: 31107222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploring the Knowledge and Preventive Practices on Isolation Precaution and Quarantine Among Health Care Workers in Ondo State, Nigeria.
    Adebimpe WO; Ibirongbe DO
    Ann Glob Health; 2019 May; 85(1):. PubMed ID: 31125195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phylogeography of Lassa Virus in Nigeria.
    Ehichioya DU; Dellicour S; Pahlmann M; Rieger T; Oestereich L; Becker-Ziaja B; Cadar D; Ighodalo Y; Olokor T; Omomoh E; Oyakhilome J; Omiunu R; Agbukor J; Ebo B; Aiyepada J; Ebhodaghe P; Osiemi B; Ehikhametalor S; Akhilomen P; Airende M; Esumeh R; Muoebonam E; Giwa R; Ekanem A; Igenegbale G; Odigie G; Okonofua G; Enigbe R; Omonegho Yerumoh E; Pallasch E; Bockholt S; Kafetzopoulou LE; Duraffour S; Okokhere PO; Akpede GO; Okogbenin SA; Odia I; Aire C; Akpede N; Tobin E; Ogbaini-Emovon E; Lemey P; Adomeh DI; Asogun DA; Günther S
    J Virol; 2019 Nov; 93(21):. PubMed ID: 31413134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increase in Lassa Fever Cases in Nigeria, January-March 2018.
    Ilori EA; Frank C; Dan-Nwafor CC; Ipadeola O; Krings A; Ukponu W; Womi-Eteng OE; Adeyemo A; Mutbam SK; Musa EO; Lasuba CLP; Alemu W; Okogbenin S; Ogbaini E; Unigwe U; Ogah E; Onoh R; Abejegah C; Ayodeji O; Ihekweazu C
    Emerg Infect Dis; 2019 May; 25(5):1026-1027. PubMed ID: 30807268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post-epidemic awareness and knowledge of Lassa fever among residents in affected community in Ibadan, Oyo State, Nigeria.
    Awosanya EJ
    Vet World; 2018 Aug; 11(8):1059-1063. PubMed ID: 30250364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk communication sources and knowledge of Lassa fever in Nigeria: An impact analysis.
    Ben-Enukora CA; Adeyeye BK; Adesina E; Ajakaiye OOP; Adekanye O
    Heliyon; 2022 Nov; 8(11):e11335. PubMed ID: 36406662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Infection pattern, case fatality rate and spread of Lassa virus in Nigeria.
    Yaro CA; Kogi E; Opara KN; Batiha GE; Baty RS; Albrakati A; Altalbawy FMA; Etuh IU; Oni JP
    BMC Infect Dis; 2021 Feb; 21(1):149. PubMed ID: 33546623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A household-based survey of knowledge, attitudes and practices towards dengue fever among local urban communities in Taiz Governorate, Yemen.
    Alyousefi TA; Abdul-Ghani R; Mahdy MA; Al-Eryani SM; Al-Mekhlafi AM; Raja YA; Shah SA; Beier JC
    BMC Infect Dis; 2016 Oct; 16(1):543. PubMed ID: 27717333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outbreak of lassa fever in Nigeria: measures for prevention and control.
    Mofolorunsho KC
    Pan Afr Med J; 2016; 23():210. PubMed ID: 27347299
    [No Abstract]   [Full Text] [Related]  

  • 33. Engaging Market Traders in Lassa Fever Campaign: Assessment of Knowledge and Risk Behaviour.
    Tobin EA; Asogun DA; Ehidiamen G; Elugbe B; Osiemi B
    West Afr J Med; 2015; 34(2):89-93. PubMed ID: 27492545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Containing a Lassa fever epidemic in a resource-limited setting: outbreak description and lessons learned from Abakaliki, Nigeria (January-March 2012).
    Ajayi NA; Nwigwe CG; Azuogu BN; Onyire BN; Nwonwu EU; Ogbonnaya LU; Onwe FI; Ekaete T; Günther S; Ukwaja KN
    Int J Infect Dis; 2013 Nov; 17(11):e1011-6. PubMed ID: 23871405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice.
    Fisher-Hoch SP; Tomori O; Nasidi A; Perez-Oronoz GI; Fakile Y; Hutwagner L; McCormick JB
    BMJ; 1995 Sep; 311(7009):857-9. PubMed ID: 7580496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ecological correlates and predictors of Lassa fever incidence in Ondo State, Nigeria 2017-2021: an emerging urban trend.
    Cadmus S; Taiwo OJ; Akinseye V; Cadmus E; Famokun G; Fagbemi S; Ansumana R; Omoluabi A; Ayinmode A; Oluwayelu D; Odemuyiwa S; Tomori O
    Sci Rep; 2023 Nov; 13(1):20855. PubMed ID: 38012226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulation of Lassa virus across the endemic Edo-Ondo axis, Nigeria, with cross-species transmission between multimammate mice.
    Adesina AS; Oyeyiola A; Obadare A; Igbokwe J; Abejegah C; Akhilomen P; Bangura U; Asogun D; Tobin E; Ayodeji O; Osoniyi O; Davis C; Thomson EC; Pahlmann M; Günther S; Fichet-Calvet E; Olayemi A
    Emerg Microbes Infect; 2023 Dec; 12(1):2219350. PubMed ID: 37288752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors associated with delayed presentation to healthcare facilities for Lassa fever cases, Nigeria 2019: a retrospective cohort study.
    Chandra NL; Bolt H; Dan-Nwafor C; Ipadeola O; Ilori E; Namara G; Olayinka AT; Ukponu W; Iniobong A; Amedu M; Akano A; Akabike KO; Okhuarobo U; Fagbemi S; Sampson E; Newitt S; Verlander NQ; Bausch DG; le Polain de Waroux O; Ihekweazu C
    BMC Infect Dis; 2021 Feb; 21(1):143. PubMed ID: 33541278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiological trends of Lassa fever in Nigeria from 2015-2021: A review.
    Grace JA; Egoh IJ; Udensi N
    Ther Adv Infect Dis; 2021; 8():20499361211058252. PubMed ID: 34868582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ebola virus disease in the eyes of a rural, agrarian community in Western Nigeria: a mixed method study.
    Idowu AB; Okafor IP; Oridota ES; Okwor TJ
    BMC Public Health; 2020 Aug; 20(1):1321. PubMed ID: 32867755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.